Literature DB >> 24768561

Bacterial persisters: formation, eradication, and experimental systems.

Sophie Helaine1, Elisabeth Kugelberg2.   

Abstract

Persisters are multidrug-tolerant bacteria that could account for the relapse of infections. For a long time, persisters have been assumed to be nonreplicating dormant bacteria, but the growth status of these recalcitrant cells is still debated. Toxin-antitoxin (TA) modules have an important role in the formation of persisters and several studies show that they can form in response to different triggers. These findings, together with the invention of new tools to study persisters, could have important implications for the development of novel therapeutics to eradicate persisting subpopulations.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  antibiotic tolerance; bacteria; infection; pathogens; persisters

Mesh:

Year:  2014        PMID: 24768561     DOI: 10.1016/j.tim.2014.03.008

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  70 in total

1.  Identification of 1-((2,4-Dichlorophenethyl)Amino)-3-Phenoxypropan-2-ol, a Novel Antibacterial Compound Active against Persisters of Pseudomonas aeruginosa.

Authors:  Veerle Liebens; Valerie Defraine; Wouter Knapen; Toon Swings; Serge Beullens; Romu Corbau; Arnaud Marchand; Patrick Chaltin; Maarten Fauvart; Jan Michiels
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

2.  NH125 kills methicillin-resistant Staphylococcus aureus persisters by lipid bilayer disruption.

Authors:  Wooseong Kim; Nico Fricke; Annie L Conery; Beth Burgwyn Fuchs; Rajmohan Rajamuthiah; Elamparithi Jayamani; Petia M Vlahovska; Frederick M Ausubel; Eleftherios Mylonakis
Journal:  Future Med Chem       Date:  2016-02-24       Impact factor: 3.808

3.  Tackling Salmonella Persister Cells by Antibiotic-Nisin Combination via Mannitol.

Authors:  Praveen Rishi; Neha Rani Bhagat; Reena Thakur; Preeti Pathania
Journal:  Indian J Microbiol       Date:  2018-03-14       Impact factor: 2.461

Review 4.  Phenotypic Heterogeneity, a Phenomenon That May Explain Why Quorum Sensing Does Not Always Result in Truly Homogenous Cell Behavior.

Authors:  Jessica Grote; Dagmar Krysciak; Wolfgang R Streit
Journal:  Appl Environ Microbiol       Date:  2015-05-29       Impact factor: 4.792

Review 5.  Continuum and discrete approach in modeling biofilm development and structure: a review.

Authors:  M R Mattei; L Frunzo; B D'Acunto; Y Pechaud; F Pirozzi; G Esposito
Journal:  J Math Biol       Date:  2017-07-24       Impact factor: 2.259

Review 6.  Relationship between the Viable but Nonculturable State and Antibiotic Persister Cells.

Authors:  Mesrop Ayrapetyan; Tiffany Williams; James D Oliver
Journal:  J Bacteriol       Date:  2018-09-24       Impact factor: 3.490

Review 7.  Immunometabolism at the interface between macrophages and pathogens.

Authors:  David G Russell; Lu Huang; Brian C VanderVen
Journal:  Nat Rev Immunol       Date:  2019-05       Impact factor: 53.106

8.  Discovery and Optimization of nTZDpa as an Antibiotic Effective Against Bacterial Persisters.

Authors:  Wooseong Kim; Andrew D Steele; Wenpeng Zhu; Erika E Csatary; Nico Fricke; Madeline M Dekarske; Elamparithi Jayamani; Wen Pan; Bumsup Kwon; Isabelle F Sinitsa; Jake L Rosen; Annie L Conery; Beth Burgwyn Fuchs; Petia M Vlahovska; Frederick M Ausubel; Huajian Gao; William M Wuest; Eleftherios Mylonakis
Journal:  ACS Infect Dis       Date:  2018-08-28       Impact factor: 5.084

Review 9.  Biofilms: an emergent form of bacterial life.

Authors:  Hans-Curt Flemming; Jost Wingender; Ulrich Szewzyk; Peter Steinberg; Scott A Rice; Staffan Kjelleberg
Journal:  Nat Rev Microbiol       Date:  2016-08-11       Impact factor: 60.633

10.  Viable but Nonculturable and Persister Cells Coexist Stochastically and Are Induced by Human Serum.

Authors:  M Ayrapetyan; T C Williams; R Baxter; J D Oliver
Journal:  Infect Immun       Date:  2015-08-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.